Longeveron LLC (LGVN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.58
• Market Cap: $14.72M
• EPS: $-0.98
• 52-Week High: $1.92
• 52-Week Low: $0.49

Market Sentiment

Longeveron LLC currently has a Bullish sentiment score of 0.29.

About Longeveron LLC

Longeveron LLC (LGVN) is an innovative clinical-stage biotechnology company headquartered in Miami, Florida, dedicated to developing groundbreaking cell therapies for life-threatening and age-related conditions. The company specializes in harnessing the potential of mesenchymal stem cells to address significant health issues such as cognitive decline and cardiac frailty. With a strong focus on scientific excellence and adherence to regulatory standards, Longeveron is committed to transforming...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Longeveron LLC and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does LGVN pay dividends?

Longeveron LLC (LGVN) does not currently pay a regular dividend.

What is LGVN's market cap?

Longeveron LLC (LGVN) has a market capitalization of $14.72M with a current stock price of $0.58.